FDA Approves Pembrolizumab for Adults and Children with TMB-H Solid Tumours
FDA also approved a companion diagnostic for pembrolizumab
Related Articles
ESMO Guidelines: Real World Cases – Webinar Series: Venous
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
Susana Banerjee | ESMO Board Member
Susana Banerjee is on the Advisory Board for Nature Reviews Clinical Oncology journal and Editorial Boards of Cancer Treatment Reviews and ESMO Open
MPs to vote on landmark Bill to create Smokefree generation
MPs to vote on legislation to create first smoke-free generation, protecting young people turning 15 this year or younger from harms of smoking
ESMO Daily Reporter
The Daily Reporter is a service from ESMO, Europe’s leading medical oncology society
Precision Oncology: Genomics Guided Care – Taxonomy and Framework
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
EMUC 2024
Plan your participation in EMUC 2024, taking place in Lisbon, Portugal, from 7 to 10 November 2024
Precision Oncology: Genomics Guided Care – Taxonomy and Framework
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.